As revealed by the strong correlation between anti-IgM and anti-C3 signal intensities (r>0.8), the IgM autoantibodies against the filaggrin peptide present in sera of both sample cohorts could activate the complement system and did not result in a significant difference between RA patients and controls regarding the C3 levels. The gene discussed is CD40LG; the disease is rheumatoid arthritis.